CME Group (NASDAQ:CME) Price Target Raised to $310.00 at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME) had its price objective increased by Deutsche Bank Aktiengesellschaft from $300.00 to $310.00 in a report published on Friday,MarketScreener reports. The firm currently has a buy rating on the financial services provider’s stock.

CME has been the subject of a number of other research reports. Barclays dropped their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Morgan Stanley increased their price objective on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. The Goldman Sachs Group lifted their target price on CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a report on Thursday, October 23rd. Jefferies Financial Group decreased their target price on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Finally, Rothschild & Co Redburn increased their price target on CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research note on Thursday, November 6th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and an average price target of $287.65.

CME Group Price Performance

Shares of NASDAQ CME traded up $1.50 during mid-day trading on Friday, reaching $285.04. The company’s stock had a trading volume of 3,339,661 shares, compared to its average volume of 2,209,226. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a 52 week low of $222.56 and a 52 week high of $290.79. The stock has a fifty day moving average of $267.33 and a two-hundred day moving average of $272.85. The firm has a market capitalization of $102.79 billion, a PE ratio of 27.62, a P/E/G ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the firm earned $2.68 EPS. The firm’s revenue was down 3.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that CME Group will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be issued a $1.25 dividend. The ex-dividend date is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is 48.45%.

Insider Activity

In other news, Director William R. Shepard acquired 262 shares of the firm’s stock in a transaction on Thursday, September 25th. The stock was acquired at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director directly owned 258,459 shares in the company, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director owned 1,091 shares of the company’s stock, valued at $287,511.23. This trade represents a 47.82% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 14,043 shares of company stock worth $3,791,486. Company insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Webster Bank N. A. raised its stake in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares in the last quarter. Caldwell Trust Co lifted its holdings in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after buying an additional 50 shares during the period. Highline Wealth Partners LLC grew its position in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 43 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in shares of CME Group during the third quarter valued at $27,000. Finally, Financial Consulate Inc. bought a new stake in shares of CME Group in the third quarter valued at about $28,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.